Taken together, these studies show HDAC6 inhibition decreases B cell activation signaling pathways and reduces PC differentiation in SLE and suggest that a critical event might be modulation of cellular metabolism. The gene discussed is HDAC6; the disease is systemic lupus erythematosus.